DMX Pharma’s €170M Exit: What Alto & Trilantic Learned at Italy’s CDMO Frontier
Alto Partners and Trilantic Europe sold 100% ...
DMX, created in 2024 via the merger of Miphar...
The management team, led by Executive Chairma...
The deal crowns a buy-and-build value-creatio...
DMX, created in 2024 via the merger of Miphar...
The management team, led by Executive Chairma...
The deal crowns a buy-and-build value-creatio...








